Eti Yoles

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Part of Takeda Pharmaceutical Co., Ltd., Sequel Therapeutics, Inc. is a company that develops immunotherapeutic vaccines. The company is based in San Diego, CA. The company was founded by Jay D. Kranzler. Sequel Therapeutics was acquired by Epimmune, Inc. from The Scripps Research Institute on October 18, 1995 for $6.90 million.

Part of Life Corp. Ltd., Biocell Pty Ltd. is an Australian company that operates a stem cell bank. The company is based in Melbourne, Australia. Biocell was acquired by CyGenics Ltd. on November 07, 2005 for $0.39 million.

Degania Silicone Ltd. manufactures medical catheters, silicone medical products and medical devices for critical care and operating rooms. Its products include silicone catheters, surgical drains systems, vessel loops, clamp covers and tubing. The firm cardiovascular products include cardiology, peripheral and accessories. The company was founded in 1984 and is headquartered in Emek Hayarden, Israel.

NeuroQuest Ltd. develops biotechnology products. It offers biomarkers and diagnostic kits that use blood tests to detect Alzheimer's and Parkinson's diseases. The company was founded by Eti Yoles, Ishay Attar and Michal Schwartz in 2008 and is headquartered in M.P. Misgav, Israel.

The Wingate Institute for Physical Education & Sports is Israel’s National Center for Physical Education and Sport. It offers courses in business administration in sports and health, alternative therapy studies, sports laws courses, courses for sports instructors, sports and health systems management courses, and courses for lifeguards. The institute was founded in 1957 and is headquartered in Netanya, Israel.

Hairstetics Ltd. engages in the development and manufacturing of hair restoration devices. The company was founded by Moshe Lapidoth, Ran Koronowski, Boaz Shenhav and Dvir Keren in 2010 and is headquartered in Omer, Israel.

Novolog Ltd. operates as a distribution company, which includes pharmaceutical, general health products, and disposable medical devices. Its partners include pharmaceutical and medical device companies. The company was founded in 1966 and is headquartered in Modiin, Israel.

V.V.T. Med Ltd. is an Israeli medical company that offers innovative solutions for the treatment of insufficiency conditions, both medical and aesthetic indications. The private company is based in Kfar Saba, Israel. The company's flagship product, ScleroSafe with V-Block, is designed to treat severely dilated and challenging Great Saphenous Vein (GSV) conditions. The company delivers a new standard of care in aesthetic and medical vein treatments by offering advanced non-thermal non-tumescent solutions. VVT Medical was founded in 2007 by Zeev Brandeis, and the CEO is Erez Tetro.

Part of Kimberly-Clark Corp., ConTIPI Medical Ltd. is a medical device manufacturer. The company is based in Caesarea, Israel.

Regenovation, Inc. develops ways to regenerate human tissue. The company is headquartered in New York, NY.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Joy Ventures (Joy Ventures) is a venture capital firm founded in 1900. The firm is headquartered in Herzeliya, Israel.

Part of Teva Pharmaceutical Industries Ltd., Teva Medical Ltd. is an Israeli company that manufactures dialysis solutions, disposable bags and medical products. The company is based in Shoham, Israel.

Part of SBI Holdings, Inc., SBI Japan-Israel Innovation Fund provides investment services. The company is based in Tokyo, Japan.

Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel.

Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA.

Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.

SBI JI Innovation Advisory Ltd (SBI JI Innovation Advisor) is a venture capital firm founded in 2017. The firm is headquartered in Tel Aviv-Yafo, Israel.

Pastorus, Inc. is a biotechnology company based in the United States that is focused on developing improved, patent-protected forms of oxytocin and other drugs to treat autism. Pastorus aims to address the particular need for drugs to treat autism, a disorder that affects over 3 million individuals in the US and tens of millions worldwide. The American company's core team of three physician-neuroscientists, each with over 20 years of industry experience, collaborate with successful experts in regulatory, clinical, manufacturing, and other domains. Recent research has demonstrated the potential to amplify oxytocin's favorable effects with a combination product, for which Pastorus has a pending patent application. The private company was founded by Jim Page and Glenn Cornett, with Glenn Cornett serving as CEO since incorporation.

Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY.

Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA.